← Browse by Condition
Medical Condition

lymphoma

Total Trials
25
Recruiting Now
25
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 3
NCT06137144 Phase 1, Phase 2
Recruiting

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

Enrollment
110 pts
Location
United States, Austr...
Sponsor
AstraZeneca
View Trial →
NCT04739813 Phase 1
Recruiting

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma

Enrollment
55 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT07305337
Recruiting

Randomised Controlled Trial of Artificial Intelligence-assisted Health Education

Enrollment
196 pts
Location
China
Sponsor
Zhongnan Hospital
View Trial →
NCT05006482 Phase 3
Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT07155954
Recruiting

Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes

Enrollment
779 pts
Location
China
Sponsor
Peking University Third Hospit...
View Trial →
NCT03580109
Recruiting

Spa Therapy for Upper or Lower Limb Lymphoedema

Enrollment
160 pts
Location
France
Sponsor
Association Francaise pour la ...
View Trial →
NCT05080166
Recruiting

UPLYFT For Lymphoma Survivors

Enrollment
74 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT07249905 Phase 1, Phase 2
Recruiting

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Enrollment
180 pts
Location
Australia
Sponsor
ModeX Therapeutics, An OPKO He...
View Trial →
NCT06550427
Recruiting

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

Enrollment
200 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT06441331 Phase 1
Recruiting

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Enrollment
20 pts
Location
United States, Spain
Sponsor
ITM Solucin GmbH
View Trial →
NCT06131801
Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
View Trial →
NCT05509751
Recruiting

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

Enrollment
60 pts
Location
Canada
Sponsor
Martine Puts
View Trial →
NCT06585124
Recruiting

Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas

Enrollment
150 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT04510766
Recruiting

Tumor Molecular Profiling in Early Phase Clinical Trials

Enrollment
40 pts
Location
Switzerland
Sponsor
Oncology Institute of Southern...
View Trial →
NCT06421805
Recruiting

Establishing Prospective Mediastinal Tumor Database of PUMCH

Enrollment
2,000 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →
NCT06895291
Recruiting

Whole Body MRI in Oncology

Enrollment
1,000 pts
Location
Italy
Sponsor
Istituto Romagnolo per lo Stud...
View Trial →
NCT05618041
Recruiting

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Enrollment
50 pts
Location
China
Sponsor
Hebei Senlang Biotechnology In...
View Trial →
NCT06510361 Phase 2
Recruiting

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Enrollment
35 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
View Trial →
NCT07015242 Phase 2
Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Enrollment
65 pts
Location
United States, Franc...
Sponsor
Juno Therapeutics, Inc., a Bri...
View Trial →
NCT05190653
Recruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy

Enrollment
152 pts
Location
Canada
Sponsor
Alberta Health Services, Calga...
View Trial →
NCT00935090
Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...
View Trial →
NCT06563505 Phase 2
Recruiting

A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

Enrollment
36 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07086989
Recruiting

Cardiovascular Risk in Children With Chronic Conditions Study

Enrollment
300 pts
Location
Hungary
Sponsor
Semmelweis University
View Trial →
NCT06814925
Recruiting

Italian Study of Patients With Lymphoma

Enrollment
1,500 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT06774326
Recruiting

Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines

Enrollment
160 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →